Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05419323 · ClinicalTrials.gov registry record
Direct Referral for Apnea Monitoring
A clinical trial of Obstructive Sleep Apnea (OSA), sponsored by VA Office of Research and Development.
- Active
- Registry status
- 6,501
- Enrollment target
- 3
- Study locations
NCT05419323: Active study of Obstructive Sleep Apnea (OSA), sponsored by VA Office of Research and Development.
NCT05419323 is a study of Obstructive Sleep Apnea (OSA) that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 6,501 participants, above the 50-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (12902% higher). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05419323, a study of Obstructive Sleep Apnea (OSA), is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- 6,501 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary objective of this project is to compare a health care delivery model, Direct Referral for Apnea Monitoring (DREAM), with initial in-person (Traditional) clinic appointments for Veterans at risk for obstructive sleep apnea (OSA). A secondary objective is to determine the negative predictive value (NPV) of home sleep apnea testing (HSAT).
Primary Outcome
For Arms 1 \& 2: Compare time from referral to sleep testing and treatment of OSA
Conditions Studied
Study Locations (3)
California
- San Francisco VA Medical Center, San Francisco, CA - San Francisco
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,501 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2026-03-31 |
What the registry record for NCT05419323 still lists
NCT05419323 is an observational study that tracks outcomes without assigning an intervention. Its 6,501 participants enrollment target places it among the larger protocols in the corpus, above the 50-participant average among 12 other Obstructive Sleep Apnea (OSA) trials with a reported enrollment target (12902% higher).
The record links to 1 condition, with Obstructive Sleep Apnea (OSA) appearing as the primary indexed condition, and to 0 interventions.
NCT05419323 reports a single indexed study location in California, Oregon, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05419323 about?
NCT05419323 is a clinical study titled "Direct Referral for Apnea Monitoring". The primary objective of this project is to compare a health care delivery model, Direct Referral for Apnea Monitoring (DREAM), with initial in-person (Traditional) clinic appointments for Veterans at risk for obstructive sleep apnea (OSA). A secondary objective is to determine the negative predicti...
What is the current status of trial NCT05419323?
This trial is currently active not recruiting. The enrollment target is 6,501 participants. The study started on 2020-08-01. Estimated completion is 2026-03-31.
What conditions does trial NCT05419323 study?
This clinical trial studies the following conditions: Obstructive Sleep Apnea (OSA).
Who is sponsoring clinical trial NCT05419323?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05419323 being conducted?
This trial has 3 study locations across California, Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obstructive Sleep Apnea (OSA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05419323's enrollment target sits among peer trials
6,501 1st of 12 higher than 12 of 12 other Obstructive Sleep Apnea (OSA) trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obstructive Sleep Apnea (OSA) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Circuit Rebreathing During CPAP Therapy
RECRUITING · NA
-
IOA Preventing Occlusal Changes With MAD Use
RECRUITING · NA
-
Inspire UAS High Apnea Hypopnea Index (AHI)/High Body Mass Index (BMI) Post-Approval Study
RECRUITING
-
Telehealth for Sleep Apnea: Effectiveness, Implementation, and Cost in the Military Health System
RECRUITING · NA
-
Diagnosing Obstructive Sleep Apnea Using Electromyography of the Muscles of the Mouth
RECRUITING
-
Low-Tech Treatments for Obstructive Sleep Apnea
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00505245 · 6,500 participants
New Assessment System in Measuring Symptom Distress in Cancer Patients
- NCT06821009 · 6,500 participants · NA
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI